Under Armour’s latest fiscal fourth quarter disappointed the market, with margin gains failing to offset a…
Anil Kumar
Paysign Sets 2026 Revenue Range of $106.5M-$110.5M as Pharma Segment Drives Q1 Growth
Paysign reported first-quarter 2026 revenue growth of 50.8% and said Pharma led the quarter, reinforcing its…
Walmart Cuts About 1,000 Corporate Jobs as It Consolidates Global Technology and Product Teams
Walmart is eliminating or relocating about 1,000 corporate workers as it consolidates parts of its global…
Full House Resorts Q1 2026 Review: Premium Valuation Faces Questions Over Sustainable Growth
Full House Resorts is under scrutiny after a Q1 2026 review said the stock trades at…
On Holding Q1 Signals Growth Beyond Near-Term Market Expectations as 2026 EBITDA Guide Rises
On Holding reported strong first-quarter results, lifted its 2026 EBITDA guide and highlighted China and apparel…
MaxCyte Q1 2026 Earnings Call Transcript Highlights Commercial Platform Execution and Investor Focus
MaxCyte’s first-quarter 2026 earnings call provided a routine but important update on the cell-engineering company’s investor…
Atea Pharmaceuticals Holds Q1 2026 Earnings Call as Investors Look for Updates on Clinical Strategy
Atea Pharmaceuticals held its first-quarter 2026 earnings call on May 12, giving investors a routine update…
Rigel Pharmaceuticals Discusses VEPPANU Licensing Agreement on M&A Call
Rigel Pharmaceuticals held a conference call on May 12, 2026 to discuss a VEPPANU licensing agreement,…
IDEAYA Biosciences Discusses Strategy and Clinical Pipeline at Bank of America Healthcare Conference 2026
IDEAYA Biosciences participated in the Bank of America Global Healthcare Conference 2026, placing the clinical-stage biotech…